Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
- 1 July 1998
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 34 (8), 1274-1281
- https://doi.org/10.1016/s0959-8049(98)00058-6
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Clinicopathologic and Prognostic Significance of an Angiogenic Factor, Thymidine Phosphorylase, in Human Colorectal CarcinomaJNCI Journal of the National Cancer Institute, 1996
- Expression of cytidine deaminase in human solid tumors and its regulation by 1 α,25-dihydroxyvitamin D3Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Expression of platelet‐derived endothelial cell growth factor/thymidine phosphorylase in human breast cancerInternational Journal of Cancer, 1995
- Angiogenic factorNature, 1992
- Comparative Antitumor Activity and Intestinal Toxicity of 5′-Deoxy-5-fluorouridine and Its Prodrug Trimethoxybenzoyl-5′-deoxy-5-fluorocytidineJapanese Journal of Cancer Research, 1990
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Pyrimidine NucleosidasesOnline Journal of Public Health Informatics, 1965